SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $72,909,000 | -37.3% | 421,907 | -58.3% | 0.02% | -40.5% |
Q4 2014 | $116,315,000 | +38.0% | 1,011,966 | +87.5% | 0.04% | +55.6% |
Q3 2014 | $84,307,000 | -8.9% | 539,596 | -28.1% | 0.03% | -10.0% |
Q2 2014 | $92,541,000 | -21.1% | 750,235 | -33.7% | 0.03% | -31.8% |
Q1 2014 | $117,220,000 | +10.2% | 1,131,363 | -4.3% | 0.04% | +12.8% |
Q4 2013 | $106,346,000 | -44.4% | 1,182,406 | -58.7% | 0.04% | -48.0% |
Q3 2013 | $191,346,000 | -4.5% | 2,861,026 | -5.6% | 0.08% | -10.7% |
Q2 2013 | $200,444,000 | – | 3,030,117 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |